Home/ Stocks/ NRXS

Neuraxis, Inc.

NRXS XASE

$7.09 +0.16 (+2.31%) ▲ 15-min delayed

Open

$6.93

High

$7.20

Low

$6.89

Volume

44.8K

Market Cap

$86.47M

About Neuraxis, Inc.

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Employees: 24 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$1.61M	$-1,761,432	$-0.18
FY 2025	$3.57M	$-7,800,555	$-0.95
Q3 2025	$811.4K	$-2,122,796	$-0.24
Q2 2025	$894.1K	$-1,690,418	$-0.22

Related Market News

No specific coverage for NRXS yet. Check out our latest market news or earnings calendar.

Get NRXS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Neuraxis, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.